Prana Doses First Patient in the “IMAGINE” Phase II Alzheimer’s Disease Trial July 17, 2013August 16, 2022
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases November 16, 2020August 16, 2022